04:48 PM EST, 12/13/2024 (MT Newswires) -- Intensity Therapeutics ( INTS ) said stockholder Armistice Capital may offer and resell almost 1.24 million shares.

The shareholder will get all of the proceeds from any sales, Intensity Therapeutics ( INTS ) said Friday in a regulatory filing.

The timing and amount of any sale are at the sole discretion of Armistice.

The shares of Intensity Therapeutics ( INTS ) fell 2.9% in after-hours trading.

Price: 2.00, Change: -0.06, Percent Change: -2.91